Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury

Journal of the Peripheral Nervous System

Volumn 9, Issue 1, 2004, Pages 15-25

  Durrenberger, Pascal F ^a   Facer, Paul ^a   Gray, Roy A ^b   Chessel, Iain P ^b   Naylor, Alan ^b   Bountra, Chas ^b   Banati, Richard B ^c   Birch, Rolfe ^d   Anand, Praveen ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Cox 2; Glial activation; Human nerve; Macrophage; Rat CCI model

Indexed keywords

ANTIBODY; CD68 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PROSTANOID;

ADULT; AGED; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; GLIA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADULT; AGED; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTORADIOGRAPHY; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISOENZYMES; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICROGLIA; MIDDLE AGED; PERIPHERAL NERVES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; SPINAL CORD;

EID: 1542408557     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2004.09104.x     Document Type: Article

References (45)

1. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S (2001). Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
2. Banati RB, Myers R, Kreutzberg GW (1997). PK ('peripheral benzodiazepine') - binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H] PK11195 binding to activated microglia. J Neurocytol 26:77-82.
3. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123:2321-2337.
4. Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Haerter PJ, Bauer J, Fiebich BL (1997). Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243: 726-731.
5. Beiche F, Klein T, Nusing R, Neuhuber W, Goppelt-Struebe M (1998). Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J Neuroimmunol 89:26-34.
6. Bennett GJ, Xie YK (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
7. Cao Y, Prescott SM (2002). Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190:279-286.
8. Dirig DM, Yaksh TL (1999). Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv Exp Med Biol 469:401-408.
9. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998). Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
10. Gazda LS, Milligan ED, Hansen MK, Twining CM, Poulos NM, Chacur M, O'Connor KA, Armstrong C, Maier SF, Watkins LR, Myers RR (2001). Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. J Peripher Nerv Syst 6: 111-129.
11. Goppelt-Struebe M, Beiche F (1997). Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus. Adv Exp Med Biol 433:213-216.
12. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD (1994). Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94:2504-2510.
13. Hoffmann C (2000). COX-2 in brain and spinal cord - implications for therapeutic use. Curr Med Chem 7:1113-1120.
14. Jaworowicz DJ Jr, Korytko PJ, Singh Lakhman S, Boje KM (1998). Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis. Brain Res Bull 46:541-546.
15. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996). COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93:2317-2321.
16. Luo C, Kallajoki M, Gross R, Mulari M, Teros T, Ylinen L, Makinen M, Laine J, Simell O (2002). Cellular distribution and contribution of cyclooxygenase COX-2 to diabetogenesis in NOD mouse. Cell Tissue Res 310:169-175.
17. Ma W, Du W, Eisenach JC (2002). Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res 937:94-99.
18. Malmberg AB, Rafferty MF, Yaksh TL (1994). Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 173:193-196.
19. Malmberg AB, Yaksh TL (1992). Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 263:136-146.
20. Matsumura K, Cao C, Ozaki M, Morii H, Nakadate K, Watanabe Y (1998). Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J Neurosci 18:6279-6289.
21. Minghetti L, Nicolini A, Polazzi E, Greco A, Perretti M, Parente L, Levi G (1999). Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol 126:1307-1314.
22. O'Neill GP, Ford-Hutchinson AW (1993). Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330:156-160.
23. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM (2003). A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 17:725-727.
24. Randall LO, Selitto JJ (1957). A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409-419.
25. Reeh PW (1994). Cellular Mechanisms of Sensory Processing, NATO ASI Series, H: Cell Biology. Vol. 79. Urban L (Ed). Springer-Verlag, Berlin, pp 119-131.
26. Resnick DK, Graham SH, Dixon CE, Marion DW (1998). Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma 15:1005-1013.
27. Robb RA, Hanson DP (1991). A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas Phys Eng Sci Med 14:9-30.
28. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-475.
29. Scholz J, Woolf CJ (2002). Can we conquer pain? Nat Neurosci 5:1062-1067.
30. Shu SY, Ju G, Fan LZ (1988). The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85:169-171.
31. Shu XQ, Mendell LM (1999). Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 96:7693-7696.
32. Sirois J, Simmons DL, Richards JS (1992). Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. J Biol Chem 267:11586-11592.
33. Smith WL, DeWitt DL, Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182.
34. Stack E, DuBois RN (2001). Regulation of cyclo-oxygenase-2. Best Pract Res Clin Gastroenterol 15:787-800.
35. Tonai T, Taketani Y, Ueda N, Nishisho T, Ohmoto Y, Sakata Y, Muraguchi M, Wada K, Yamamoto S (1999). Possible involvement of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats. J Neurochem 72:302-309.
36. Vane JR, Bakhle YS, Botting RM (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120.
37. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP (1997). PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50:345-353.
38. Watkins LR, Maier SF (2000). The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 51:29-57.
39. Watkins LR, Maier SF (2002). Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981-1011.
40. Watkins LR, Milligan ED, Maier SF (2001). Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
41. Woolf CJ, Costigan M (1999). Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 96:7723-7730.
42. Woolf CJ, Salter MW (2000). Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.
43. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC (2001). The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 21: 5847-5853.
44. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993). Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.
45. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL (2001). Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 57:952-956.